<DOC>
	<DOCNO>NCT01595425</DOCNO>
	<brief_summary>This study investigate whether D961H sachet 20 mg bioequivalent D961H HPMC capsule 20 mg follow repeat oral dos , evaluate safety tolerability two formulation healthy male Japanese subject .</brief_summary>
	<brief_title>Bioequivalence Study Comparing D961H Sachet D961H Capsule Japanese Healthy Male Subjects</brief_title>
	<detailed_description>A Phase I , Open-label , Randomized , Single-center , 2-way Crossover Bioequivalence Study Comparing Pellets Based Sachet Formulation D961H 20 mg Commercial HPMC Capsule D961H 20 mg After Repeated Oral Administration Japanese Healthy Male Subjects</detailed_description>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>1 . Provision sign date , write informed consent prior study specific procedures 2 . Japanese healthy male subject age 20 45 year age 3 . Body Mass Index 1927 kg/m2 body weight 5085 kg 4 . Clinically normal finding 5 . Classified homoEM ( extensive metabolizers ) accord genotype CYP2C19 1 . Significant clinical illness 2 . Past present cardiac , renal , hepatic , neurological gastrointestinal disease 3 . Clinical significant condition could modify absorption investigational product 4 . Past present severe allergic disease , hypersensitivity food drug , allergic symptom require medical intervention</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bioequivalence ,</keyword>
	<keyword>pharmacokinetics ,</keyword>
	<keyword>safety ,</keyword>
	<keyword>esomeprazole ,</keyword>
	<keyword>Japanese ,</keyword>
	<keyword>healthy subject ,</keyword>
	<keyword>homo-EM</keyword>
</DOC>